Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bronchoscopy | 8 | 2023 | 227 | 0.670 |
Why?
|
| Chylothorax | 3 | 2019 | 20 | 0.310 |
Why?
|
| Lymphography | 2 | 2018 | 13 | 0.270 |
Why?
|
| Thoracoscopy | 2 | 2019 | 60 | 0.260 |
Why?
|
| Stents | 2 | 2020 | 564 | 0.230 |
Why?
|
| Pulmonary Medicine | 1 | 2024 | 78 | 0.200 |
Why?
|
| Airway Management | 1 | 2024 | 81 | 0.200 |
Why?
|
| Robotics | 1 | 2004 | 90 | 0.180 |
Why?
|
| Surgical Procedures, Operative | 1 | 2004 | 271 | 0.160 |
Why?
|
| Fellowships and Scholarships | 1 | 2024 | 354 | 0.160 |
Why?
|
| Dyspnea | 1 | 2022 | 250 | 0.160 |
Why?
|
| Academic Medical Centers | 3 | 2017 | 554 | 0.150 |
Why?
|
| Constriction, Pathologic | 1 | 2020 | 249 | 0.150 |
Why?
|
| Lung Neoplasms | 2 | 2023 | 2664 | 0.150 |
Why?
|
| Biopsy | 3 | 2017 | 1082 | 0.150 |
Why?
|
| Diagnostic Imaging | 1 | 2022 | 337 | 0.150 |
Why?
|
| Thoracentesis | 1 | 2019 | 6 | 0.150 |
Why?
|
| Respiratory Tract Diseases | 1 | 2020 | 175 | 0.140 |
Why?
|
| Airway Obstruction | 2 | 2020 | 153 | 0.140 |
Why?
|
| Chyle | 1 | 2018 | 4 | 0.140 |
Why?
|
| Pericardial Effusion | 1 | 2018 | 22 | 0.140 |
Why?
|
| Magnetic Resonance Imaging, Interventional | 1 | 2018 | 30 | 0.140 |
Why?
|
| Critical Care | 1 | 2024 | 702 | 0.140 |
Why?
|
| Pleural Effusion | 1 | 2019 | 59 | 0.140 |
Why?
|
| Lymphatic Abnormalities | 1 | 2017 | 20 | 0.130 |
Why?
|
| Lung Transplantation | 1 | 2020 | 332 | 0.130 |
Why?
|
| Pneumothorax | 1 | 2017 | 52 | 0.120 |
Why?
|
| Cryosurgery | 1 | 2017 | 46 | 0.120 |
Why?
|
| Bronchial Neoplasms | 1 | 2016 | 15 | 0.120 |
Why?
|
| Pericarditis | 1 | 2016 | 11 | 0.120 |
Why?
|
| Cryotherapy | 1 | 2016 | 21 | 0.120 |
Why?
|
| Empyema, Pleural | 1 | 2016 | 13 | 0.120 |
Why?
|
| Embolization, Therapeutic | 1 | 2018 | 242 | 0.120 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2022 | 1189 | 0.100 |
Why?
|
| Hemorrhage | 1 | 2017 | 822 | 0.090 |
Why?
|
| Image-Guided Biopsy | 2 | 2023 | 41 | 0.090 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2017 | 664 | 0.080 |
Why?
|
| Fluoroscopy | 2 | 2023 | 180 | 0.080 |
Why?
|
| Sensitivity and Specificity | 2 | 2019 | 1997 | 0.060 |
Why?
|
| Phosphotyrosine | 1 | 2006 | 38 | 0.060 |
Why?
|
| Growth Inhibitors | 1 | 2006 | 39 | 0.060 |
Why?
|
| Humans | 17 | 2024 | 145474 | 0.060 |
Why?
|
| Antigens, Differentiation | 1 | 2005 | 76 | 0.060 |
Why?
|
| Antigens, Surface | 1 | 2005 | 155 | 0.060 |
Why?
|
| Receptors, Immunologic | 1 | 2006 | 208 | 0.050 |
Why?
|
| Lymphocyte Activation | 2 | 2006 | 1132 | 0.050 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2005 | 187 | 0.050 |
Why?
|
| Lung | 1 | 2017 | 4106 | 0.050 |
Why?
|
| Neurosurgery | 1 | 2004 | 41 | 0.050 |
Why?
|
| Retrospective Studies | 4 | 2023 | 17291 | 0.050 |
Why?
|
| Urologic Surgical Procedures | 1 | 2004 | 118 | 0.050 |
Why?
|
| Endoscopic Ultrasound-Guided Fine Needle Aspiration | 1 | 2022 | 61 | 0.050 |
Why?
|
| Pelvic Pain | 1 | 2002 | 42 | 0.040 |
Why?
|
| Endosonography | 1 | 2023 | 160 | 0.040 |
Why?
|
| Forecasting | 1 | 2004 | 390 | 0.040 |
Why?
|
| Anesthesiology | 1 | 2024 | 179 | 0.040 |
Why?
|
| Male | 8 | 2024 | 72842 | 0.040 |
Why?
|
| Abdominal Pain | 1 | 2002 | 149 | 0.040 |
Why?
|
| Orthopedic Procedures | 1 | 2004 | 244 | 0.040 |
Why?
|
| Treatment Outcome | 4 | 2020 | 11772 | 0.040 |
Why?
|
| Sports Medicine | 1 | 2002 | 118 | 0.040 |
Why?
|
| Equipment Failure | 1 | 2020 | 115 | 0.040 |
Why?
|
| Lymph Nodes | 1 | 2022 | 503 | 0.040 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2006 | 1140 | 0.040 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2022 | 530 | 0.040 |
Why?
|
| Tuberculosis, Pleural | 1 | 2019 | 7 | 0.040 |
Why?
|
| Feasibility Studies | 1 | 2004 | 1111 | 0.040 |
Why?
|
| Pleura | 1 | 2019 | 28 | 0.040 |
Why?
|
| Respiratory Function Tests | 1 | 2020 | 544 | 0.030 |
Why?
|
| Neoplasm Staging | 1 | 2022 | 1471 | 0.030 |
Why?
|
| Safety | 1 | 2020 | 358 | 0.030 |
Why?
|
| Fungi | 1 | 2019 | 121 | 0.030 |
Why?
|
| Thoracic Duct | 1 | 2017 | 6 | 0.030 |
Why?
|
| Rosaniline Dyes | 1 | 2017 | 15 | 0.030 |
Why?
|
| Female | 6 | 2024 | 78844 | 0.030 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2004 | 610 | 0.030 |
Why?
|
| Bronchi | 1 | 2019 | 263 | 0.030 |
Why?
|
| T-Lymphocytes | 1 | 2005 | 1996 | 0.030 |
Why?
|
| Pennsylvania | 1 | 2017 | 138 | 0.030 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2019 | 507 | 0.030 |
Why?
|
| Iatrogenic Disease | 1 | 2017 | 74 | 0.030 |
Why?
|
| Sputum | 1 | 2018 | 302 | 0.030 |
Why?
|
| Biofilms | 1 | 2019 | 292 | 0.030 |
Why?
|
| Clinical Competence | 1 | 2024 | 1243 | 0.030 |
Why?
|
| Radiography, Thoracic | 1 | 2017 | 172 | 0.030 |
Why?
|
| CD28 Antigens | 2 | 2006 | 59 | 0.030 |
Why?
|
| Cost-Benefit Analysis | 1 | 2019 | 639 | 0.030 |
Why?
|
| Signal Transduction | 2 | 2006 | 5216 | 0.030 |
Why?
|
| Recurrence | 1 | 2018 | 1138 | 0.030 |
Why?
|
| Hypoxia | 1 | 2022 | 1199 | 0.030 |
Why?
|
| Contrast Media | 1 | 2017 | 497 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2004 | 3747 | 0.030 |
Why?
|
| Bacteria | 1 | 2019 | 765 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2020 | 3623 | 0.020 |
Why?
|
| Middle Aged | 3 | 2020 | 36215 | 0.020 |
Why?
|
| Phenotype | 1 | 2020 | 3155 | 0.020 |
Why?
|
| Microbiota | 1 | 2019 | 730 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2024 | 6066 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2016 | 1747 | 0.020 |
Why?
|
| Aged | 2 | 2020 | 26153 | 0.020 |
Why?
|
| Vanadates | 1 | 2006 | 17 | 0.020 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 6 | 1 | 2006 | 10 | 0.020 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2006 | 22 | 0.020 |
Why?
|
| Okadaic Acid | 1 | 2005 | 15 | 0.010 |
Why?
|
| Risk Factors | 1 | 2020 | 10885 | 0.010 |
Why?
|
| Adult | 2 | 2020 | 40777 | 0.010 |
Why?
|
| Dimerization | 1 | 2006 | 189 | 0.010 |
Why?
|
| Oncogene Protein v-akt | 1 | 2005 | 23 | 0.010 |
Why?
|
| United States | 1 | 2004 | 16098 | 0.010 |
Why?
|
| Amino Acid Motifs | 1 | 2006 | 219 | 0.010 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2005 | 66 | 0.010 |
Why?
|
| Phosphatidylinositols | 1 | 2005 | 57 | 0.010 |
Why?
|
| CD3 Complex | 1 | 2005 | 112 | 0.010 |
Why?
|
| CTLA-4 Antigen | 1 | 2005 | 105 | 0.010 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2006 | 167 | 0.010 |
Why?
|
| Interleukin-2 | 1 | 2006 | 440 | 0.010 |
Why?
|
| Protein Transport | 1 | 2006 | 442 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2005 | 762 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 2005 | 1048 | 0.010 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2005 | 265 | 0.010 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2005 | 382 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2006 | 666 | 0.010 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2006 | 456 | 0.010 |
Why?
|
| Osteitis | 1 | 2002 | 5 | 0.010 |
Why?
|
| Psoas Muscles | 1 | 2002 | 14 | 0.010 |
Why?
|
| Antigens, CD | 1 | 2005 | 558 | 0.010 |
Why?
|
| Hip | 1 | 2002 | 57 | 0.010 |
Why?
|
| Tendinopathy | 1 | 2002 | 32 | 0.010 |
Why?
|
| Endometriosis | 1 | 2002 | 58 | 0.010 |
Why?
|
| Pelvis | 1 | 2002 | 125 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2005 | 1707 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2006 | 2507 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2002 | 1808 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2005 | 2597 | 0.010 |
Why?
|
| Mutation | 1 | 2006 | 4075 | 0.010 |
Why?
|
| Mice | 1 | 2006 | 18329 | 0.000 |
Why?
|
| Animals | 1 | 2006 | 38030 | 0.000 |
Why?
|